Cargando…

An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research

This communication provides a compilation on aspects of COVID-19 infection control measures, describes the potential role of therapeutic plasma exchange to reduce fatality rates, addresses precautions concerning dexamethasone pharmacotherapy and updates the current status on the availability of vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Putter, Jeffrey S., Seghatchian, Jerard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471798/ https://www.ncbi.nlm.nih.gov/pubmed/32948465 http://dx.doi.org/10.1016/j.transci.2020.102934

Ejemplares similares

T-cell lymphocytopenia: An omnipresent predictor of morbidity and mortality in consequence of SARS-CoV disease and influenza A infections
por: Putter, Jeffrey S., et al.
Publicado: (2023)

Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!!
por: Seghatchian, Jerard, et al.
Publicado: (2020)

New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic
por: Seghatchian, Jerard
Publicado: (2021)

Therapeutic Use of Convalescent Plasma in COVID-19 Infected Patients with Concomitant Hematological Disorders
por: Lanza, Francesco, et al.
Publicado: (2021)

Updates on Stem Cell Therapy in Transfusion Medicine, New Approaches to RBC Substitution Therapy, the Use of IFC for the Assessment of Extracellular- Derived Vesicles/Exosomes
por: Seghatchian, Jerard
Publicado: (2020)

Editorial: Time to explore the missing links: from activated platelets and platelet extracellular vesicles in SARS-CoV-2 infection, through heterogeneity in the host physiological, immuno-inflammatory and haemostatic responses to mRNA-based vaccine or infection induced polyclonal neutralizing antibodies and passive immunity
por: Seghatchian, Jerard
Publicado: (2022)

Facts and challenges on global deployment of vaccines for the immunotherapy of the evolving SARS Cov-2 variants: What a new year, with a fast spreading South African and the most fearful Brazilian variants, as the unwanted gifts, imposing enormous crises to surmount
por: Seghatchian, Jerard
Publicado: (2021)

Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
por: Seghatchian, Jerard
Publicado: (2022)

Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes
por: Seghatchian, Jerard
Publicado: (2022)

Spotlight on SARS CoV-2 infection inducing autoimmunity, through the formation of autoantibody to self hemostatic components or to host cells, often leading to severe thrombotic or bleeding events
por: Seghatchian, Jerard
Publicado: (2023)

“Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed!
por: Burnouf, Thierry, et al.
Publicado: (2014)

Platelet and extracellular vesicles in COVID-19 infection and its vaccines
por: Goubran, Hadi, et al.
Publicado: (2022)

The secrets of human stem cell-derived transfusable RBC for targeted large-scale production and clinical applications: A fresh look into what we need most and lessons to be learned
por: Seghatchian, Jerard
Publicado: (2020)

In vitro mass production of reproducible human cells destined for substitution therapy: Challenges for development of functional materials for what we need most in transfusion!
por: Seghatchian, Jerard
Publicado: (2020)

Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes
por: Amiral, Jean, et al.
Publicado: (2023)

Spotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron
por: Seghatchian, Jerard, et al.
Publicado: (2022)

Trends and targets of various types of stem cell derived transfusable RBC substitution therapy: Obstacles that need to be converted to opportunity
por: Lanza, Francesco, et al.
Publicado: (2020)

Ebola virus convalescent blood products: Where we are now and where we may need to go
por: Burnouf, Thierry, et al.
Publicado: (2014)

Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products
por: Drew, Victor J., et al.
Publicado: (2018)

Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?
por: Amiral, Jean, et al.
Publicado: (2020)

Cell culture – Fact and fiction
por: Smit Sibinga, Cees Th., et al.
Publicado: (2020)

Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
por: Irusen, Elvis M., et al.
Publicado: (2020)

Update on Pharmacotherapy in Psychodermatological Disorders
por: Shenoi, Shrutakirthi D., et al.
Publicado: (2020)

On the Quest for In Vitro Platelet Production by Re-Tailoring the Concepts of Megakaryocyte Differentiation
por: Martínez-Botía, Patricia, et al.
Publicado: (2020)

SARS-CoV-2 and cancer: the intriguing and informative cross-talk
por: Goubran, Hadi, et al.
Publicado: (2022)

Update on pharmacotherapies for cholestatic liver disease
por: Ali, Ahmad H., et al.
Publicado: (2016)

Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions
por: Sharma, Anjalee, et al.
Publicado: (2016)

WITHDRAWN: New Generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic
por: Seghatchian, J.
Publicado: (2021)

Update on the pharmacotherapy of cerebellar and central vestibular disorders
por: Kalla, Roger, et al.
Publicado: (2016)

Update on pharmacotherapy for ocular surface squamous neoplasia
por: Al Bayyat, Ghada, et al.
Publicado: (2019)

Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike
por: Seghatchian, J., et al.
Publicado: (2020)

Machine Learning as a Precision-Medicine Approach to Prescribing COVID-19 Pharmacotherapy with Remdesivir or Corticosteroids
por: Lam, Carson, et al.
Publicado: (2021)

WITHDRAWN: Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike
por: Seghatchian, J., et al.
Publicado: (2020)

Research in pharmacotherapy for erectile dysfunction
por: Ryu, Ji-Kan, et al.
Publicado: (2017)

Advances in research on pharmacotherapy of sarcopenia
por: Feike, Yang, et al.
Publicado: (2021)

Updates in pharmacotherapy of heart failure with reduced ejection fraction
por: Espinoza, Clifton, et al.
Publicado: (2021)

Editorial: New Trends and Approaches in Perioperative Pharmacotherapy: An Update
por: Soghomonyan, S., et al.
Publicado: (2021)

Pharmacotherapy of Painful Diabetic Neuropathy: A Clinical Update
por: James, Cornelius Fernandez, et al.
Publicado: (2022)

Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis
por: Thong, Lorraine, et al.
Publicado: (2023)

Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk
por: Pierno, Sabata, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i9hjao68juk6gjn2m3d7eq9hqf